Kim W. Benner

543 total citations
24 papers, 382 citations indexed

About

Kim W. Benner is a scholar working on Pediatrics, Perinatology and Child Health, Infectious Diseases and Pharmacology. According to data from OpenAlex, Kim W. Benner has authored 24 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 5 papers in Infectious Diseases and 5 papers in Pharmacology. Recurrent topics in Kim W. Benner's work include Patient Safety and Medication Errors (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Pharmaceutical studies and practices (5 papers). Kim W. Benner is often cited by papers focused on Patient Safety and Medication Errors (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Pharmaceutical studies and practices (5 papers). Kim W. Benner collaborates with scholars based in United States. Kim W. Benner's co-authors include Nancy M. Tofil, Margaret K. Winkler, Marjorie Lee White, Jeffrey A. Alten, Spencer H. Durham, Priya Prabhakaran, Jeffrey A. Alten, Brian M. Varisco, Karl F. Gumpper and Kevin Buckley and has published in prestigious journals such as JAMA, PEDIATRICS and Pediatric Pulmonology.

In The Last Decade

Kim W. Benner

24 papers receiving 360 citations

Peers

Kim W. Benner
Rajesh Venkataraman United States
Rachel Meyers United States
F Barale France
Nilam Patel United States
Hadeel Alkofide Saudi Arabia
Kim W. Benner
Citations per year, relative to Kim W. Benner Kim W. Benner (= 1×) peers Michael Legal

Countries citing papers authored by Kim W. Benner

Since Specialization
Citations

This map shows the geographic impact of Kim W. Benner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim W. Benner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim W. Benner more than expected).

Fields of papers citing papers by Kim W. Benner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim W. Benner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim W. Benner. The network helps show where Kim W. Benner may publish in the future.

Co-authorship network of co-authors of Kim W. Benner

This figure shows the co-authorship network connecting the top 25 collaborators of Kim W. Benner. A scholar is included among the top collaborators of Kim W. Benner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim W. Benner. Kim W. Benner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davis, Brittney H., et al.. (2023). Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis. Clinical and Translational Science. 16(4). 662–672. 5 indexed citations
2.
Thomas, Michael C., Kim W. Benner, & Peter J. Hughes. (2022). Availability and characteristics of teaching and learning curriculum programs for first year pharmacy residents: A national perspective. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5(7). 682–688. 1 indexed citations
3.
Ryan, Kevin J., Hector Gutierrez, Luz Helena Gutierrez Sanchez, et al.. (2021). Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis. Journal of Cystic Fibrosis. 21(1). e8–e10. 15 indexed citations
4.
Benner, Kim W., et al.. (2021). Achieving Vancomycin Troughs Within Goal Range in Low Birth Weight Neonates. The Journal of Pediatric Pharmacology and Therapeutics. 26(1). 56–61. 3 indexed citations
5.
Benner, Kim W., et al.. (2020). Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis. Pediatric Pulmonology. 55(12). 3337–3342. 11 indexed citations
6.
Benner, Kim W., et al.. (2020). Student organization prevalence and structures in US schools of pharmacy. Currents in Pharmacy Teaching and Learning. 12(5). 544–548. 1 indexed citations
7.
Eiland, Lea S., et al.. (2018). ASHP–PPAG Guidelines for Providing Pediatric Pharmacy Services in Hospitals and Health Systems. The Journal of Pediatric Pharmacology and Therapeutics. 23(3). 177–191. 9 indexed citations
8.
Eiland, Lea S., et al.. (2018). ASHP–PPAG Guidelines for Providing Pediatric Pharmacy Services in Hospitals and Health Systems. American Journal of Health-System Pharmacy. 75(15). 1151–1165. 24 indexed citations
9.
Benner, Kim W., et al.. (2016). Knowledge Gain of Pharmacy Students and Pharmacists Comparing Simulation Versus Traditional Learning Methodology. The Journal of Pediatric Pharmacology and Therapeutics. 21(6). 476–485. 9 indexed citations
10.
Oliver, Sara E., et al.. (2015). Chromobacterium Violaceum Sepsis: Rethinking Conventional Therapy to Improve Outcome. American Journal of Case Reports. 16. 740–744. 18 indexed citations
11.
Benner, Kim W., et al.. (2012). ASHP therapeutic position statement on the institutional use of 0.9% sodium chloride injection to maintain patency of peripheral indwelling intermittent infusion devices. American Journal of Health-System Pharmacy. 69(14). 1252–1254. 5 indexed citations
12.
Tofil, Nancy M., et al.. (2011). Pediatric Intensive Care Simulation Course: A New Paradigm in Teaching. Journal of Graduate Medical Education. 3(1). 81–87. 34 indexed citations
13.
Benner, Kim W. & Spencer H. Durham. (2011). Meperidine Restriction in a Pediatric Hospital. The Journal of Pediatric Pharmacology and Therapeutics. 16(3). 185–190. 9 indexed citations
14.
Benner, Kim W., et al.. (2010). Verbesserung der Leistungsfähigkeit durch Akupunktur im Ausdauersport. Sportverletzung · Sportschaden. 24(3). 140–143. 5 indexed citations
15.
Tofil, Nancy M., et al.. (2010). Use of Simulation to Enhance Learning in a Pediatric Elective. American Journal of Pharmaceutical Education. 74(2). 21–21. 45 indexed citations
16.
Durham, Spencer H., et al.. (2009). Severe invasive community-associated methicillin-resistant Staphylococcus aureus infections in previously healthy children *. Pediatric Critical Care Medicine. 10(3). 323–327. 36 indexed citations
17.
Benner, Kim W., et al.. (2009). Correlation of Vancomycin Dosing to Serum Concentrations in Pediatric Patients: A Retrospective Database Review. The Journal of Pediatric Pharmacology and Therapeutics. 14(2). 86–93. 27 indexed citations
18.
Alten, Jeffrey A., et al.. (2009). Pediatric Off-label Use of Recombinant Factor VIIa. PEDIATRICS. 123(3). 1066–1072. 29 indexed citations
19.
Tofil, Nancy M., et al.. (2008). Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: A comparison of gastric pH. Journal of Critical Care. 23(3). 416–421. 19 indexed citations
20.
Tofil, Nancy M., et al.. (2006). The use of enteral naloxone to treat opioid-induced constipation in a pediatric intensive care unit*. Pediatric Critical Care Medicine. 7(3). 252–254. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026